Cisplatin

Alkylating Agent
DB00515
Approved Indication

For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.

4 Targets
0 Resistance Mutations
0 References
3D Structure No structure available
No co-crystal structure available
Mechanism of Action

Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations.

Details
DrugBank ID DB00515 ↗
Approval Date 2000-06-01
Molecular Weight 298.035 g/mol
Drug Class Alkylating Agent
ATC Codes L01XA01
Synonyms CDDP, Cis-DDP
SMILES
N[Pt](N)(Cl)Cl
ADMET Profile
Computing properties…